Proto Labs Announces 3.5M Share Public Offering of Common Stock
Proto Labs (NYSE: PRLB) announced today the commencement of a public offering of 3.6 million shares of its common stock, of which 3.5 million shares will be sold by certain selling shareholders and 100,000 shares will be sold by Proto Labs. In addition, certain of the selling shareholders will grant the underwriters an option to purchase up to an additional 540,000 shares of common stock. Proto Labs will not receive any of the proceeds from the sale of the shares sold by the selling shareholders.
The principal purposes of this offering are to facilitate an orderly distribution of shares for the selling shareholders and to increase Proto Labs' public float. Proto Labs intends to use the proceeds that it receives from the offering to pay the expenses that it incurs in connection with the offering and for working capital and general corporate purposes.
Morgan Stanley & Co. LLC and Piper Jaffray & Co. are the joint book-running managers for the offering. This offering will be made only by means of a prospectus. A copy of the preliminary prospectus, when available, may be obtained from the offices of Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at email@example.com; or Piper Jaffray & Co., Attention: Prospectus Department, at 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, or by email at firstname.lastname@example.org
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. The registration statement on Form S-1 may be accessed through the SEC's website at edgar.sec.gov.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.